During the early stages of a new influenza pandemic, travel restriction is an immediate and non-pharmaceutical means of retarding incidence growth. It extends the timeframe of effective mitigation, especially when the characteristics of the emerging virus are unknown. Chong and Chung (2012) describe a study in which they used the 2009 influenza A pandemic as a case study to evaluate the impact of regulating air, sea, and land transport. Other government strategies, namely, antivirals and hospitalizations, were also evaluated.
Â
Hong Kong arrivals from 44 countries via air, sea, and land transports were imported into a discrete stochastic Susceptible, Exposed, Infectious and Recovered (SEIR) host-flow model. The model allowed a number of latent and infectious cases to pass the border, which constitutes a source of local disease transmission. The researchers also modeled antiviral and hospitalization prevention strategies to compare the effectiveness of these control measures. Baseline reproduction rate was estimated from routine surveillance data.
Â
Regarding air travel, the main route connected to the influenza source area should be targeted for travel restrictions; imposing a 99 percent air travel restriction delayed the epidemic peak by up to two weeks. Once the pandemic was established in China, the strong land connection between Hong Kong and China rendered Hong Kong vulnerable. Antivirals and hospitalization were found to be more effective on attack rate reductions than travel restrictions. Combined strategies (with 99 percent restriction on all transport modes) deferred the peak for long enough to establish a vaccination program.
Â
The researchers say their study suggests that air travel restrictions should be priorities for consideration when a new influenza pandemic begins overseas. When the pandemic is initiated in China or other places where there is land travel to Hong Kong, land travel restrictions should also be a priority. If restrictions are able to cover 99 percent of travelers with the use of antiviral and hospitalization, the resulting pandemic delays are possible to allow vaccine production; if the restrictions cannot cover 90 percent or more of travelers, then the peak time will happen sooner. In this case, control
measures such as antiviral should be enacted earlier to alleviate the epidemic growth. To date, travel restrictions have yet to gain widespread social acceptance, but the benefits may significantly outweigh the costs, especially
when a new and highly intrusive virus emerges. Their research is published in BMC Infectious Diseases.
Reference: Chong KC and Chung Zee BC. Modeling the impact of air, sea, and land travel restrictions supplemented by other interventions on the emergence of a new influenza pandemic virus. BMC Infectious Diseases 2012, 12:309 doi:10.1186/1471-2334-12-309
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.